Medical Care Technologies Inc. (OTCBB: MDCE) today announced that the company has begun development of a secure Cellular-Based Tele-Health Suite™ that enables users to easily transmit vital signs data via the cellular network, to healthcare professionals utilizing the Medsuite™ application. Tele-Health Suite™ is a provision of healthcare services using telecommunication technology to provide healthcare solutions over a geographic distance. Cellular access to Tele-Health Suite™ allows patients to keep their health regime intact, while being mobile at the same time. According to statistics, China’s mobile phone usage has been accelerating at a rapid rate in recent years. The nation hit the 400 million subscriber mark in February 2006; it then took 16 months to top the 500 million mark in June 2007 and another 12 months to reach the 600 million mark. Currently, China has over 700 million mobile phone users in its cellular network.
As the global healthcare market slowly changes from a traditional healthcare system to a more modern electronic healthcare system, that utilizes technology through increased usage of electronic health systems like Tele-Health Suite™, we will see limited need for the hospitalization and physical movement of patients as well as enriched health system service coverage. Tele-Health Suite™ will ultimately decrease hospital visits, thereby decreasing the overall cost of healthcare expenditure. Ning Wu, president of Medical Care Technologies, stated, “We are of the belief that Telehealth through cellular networks is going to be an important component of the modern healthcare system and will decrease pressure on the existing healthcare infrastructure. We think the Chinese market will witness substantial growth in the near future as a result of an increasing population, increase in life expectancy, increasing per capita income, and the substantial increase in Internet and cellular phone penetration in China.”
About Medical Care Technologies Inc.
Medical Care Technologies Inc. (www.medicaretech.com) is traded under the symbol MDCE on the OTCBB and is based in London, England. The Company is in the process of moving its portfolio of oil resources into medical care technologies. The products/services that the company hopes to acquire are intended to constitute a healthcare delivery and wellness site, dedicated to helping Asian consumers live healthier, more balanced lives. MDCE is planning to provide advanced connectivity, internationally standardized and secure business technology and information systems to assist the Asian health industry — physicians, pharmacists, medical institutions, and consumers — in accessing medical resources, health services, education, wellness and pharmaceutical products throughout Asia. MDCE is planning to distribute and provide services at a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Nutraceuticals. Further information on the Company can be found at www.sec.gov and the company’s website at www.medicaretech.com